Follow
Mark Jaroszeski
Mark Jaroszeski
Verified email at usf.edu
Title
Cited by
Cited by
Year
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy
LM Mir, LF Glass, G Serša, J Teissie, C Domenge, D Miklavčič, ...
British journal of cancer 77 (12), 2336-2342, 1998
5971998
In vivo gene electroinjection and expression in rat liver
R Heller, M Jaroszeski, A Atkin, D Moradpour, R Gilbert, J Wands, ...
FEBS letters 389 (3), 225-228, 1996
5581996
Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo
G Niu, R Heller, R Catlett-Falcone, D Coppola, M Jaroszeski, W Dalton, ...
Cancer research 59 (20), 5059-5063, 1999
4761999
Theory and in vivo application of electroporative gene delivery
S Somiari, J Glasspool-Malone, JJ Drabick, RA Gilbert, R Heller, ...
Molecular Therapy 2 (3), 178-187, 2000
4102000
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy
R Heller, MJ Jaroszeski, LF Glass, JL Messina, DP Rapaport, RC DeConti, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1996
3761996
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin
R Heller, MJ Jaroszeski, DS Reintgen, CA Puleo, RC DeConti, RA Gilbert, ...
Cancer 83 (1), 148-157, 1998
3541998
Needle electrodes for mediated delivery of drugs and genes
GA Hofmann, RA Gilbert, Y Hayakawa, R Heller, MJ Jaroszeski
US Patent 5,702,359, 1997
3271997
Clinical applications of electrochemotherapy
R Heller, R Gilbert, MJ Jaroszeski
Advanced drug delivery reviews 35 (1), 119-129, 1999
2661999
Novel electrode designs for electrochemotherapy
RA Gilbert, MJ Jaroszeski, R Heller
Biochimica et Biophysica Acta (BBA)-General Subjects 1334 (1), 9-14, 1997
2211997
Toxicity of anticancer agents mediated by electroporation in vitro
MJ Jaroszeski, V Dang, C Pottinger, J Hickey, R Gilbert, R Heller
Anti-Cancer Drugs 11 (3), 201-208, 2000
2132000
Fundamentals of flow cytometry
MJ Jaroszeski, G Radcliff
Molecular biotechnology 11, 37-53, 1999
1551999
Bleomycin-mediated electrochemotherapy of metastatic melanoma
LF Glass, ML Pepine, NA Fenske, M Jaroszeski, DS Reintgen, R Heller
Archives of dermatology 132 (11), 1353-1357, 1996
1491996
In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity
L Heller, C Pottinger, MJ Jaroszeski, R Gilbert, R Heller
Melanoma research 10 (6), 577-583, 2000
1422000
Bleomycin-mediated electrochemotherapy of basal cell carcinoma
LF Glass, NA Fenske, M Jaroszeski, R Perrott, DT Harvey, DS Reintgen, ...
Journal of the American Academy of Dermatology 34 (1), 82-86, 1996
1381996
Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma
LF Glass, M Jaroszeski, R Gilbert, DS Reintgen, R Heller
Journal of the American Academy of Dermatology 37 (4), 596-599, 1997
1331997
Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo
L Heller, MJ Jaroszeski, D Coppola, C Pottinger, R Gilbert, R Heller
Gene Therapy 7 (10), 826-829, 2000
1322000
Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy
R Heller, M Jaroszeski, J Leo-Messina, R Perrot, N Van Voorhis, ...
Bioelectrochemistry and Bioenergetics 36 (1), 83-87, 1995
1321995
In vivo gene delivery by electroporation
MJ Jaroszeski, R Gilbert, C Nicolau, R Heller
Advanced drug delivery reviews 35 (1), 131-137, 1999
1221999
Electrochemotherapy, electrogenetherapy, and transdermal drug delivery: electrically mediated delivery of molecules to cells
MJ Jaroszeski, R Heller, R Gilbert
Humana Press, 2000
121*2000
Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation
R Heller, J Schultz, ML Lucas, MJ Jaroszeski, LC Heller, RA Gilbert, ...
DNA and cell biology 20 (1), 21-26, 2001
1202001
The system can't perform the operation now. Try again later.
Articles 1–20